The present invention relates to the use of a direct antibody, with a high degree of affinity and specificity, against the extracellular domain of the hemichannels formed by connexin 26 (Cx26, encoded by GJB2), connexin 30 (Cx30, encoded by GJB6) and/or connexin 32 (Cx32, encoded by GJB1), to treat brain tumours and epilepsy correlated thereto or to reduce or inhibit the development thereof.

ANTIBODY FOR TREATING BRAIN TUMOURS AND EPILEPSY CORRELATED

MAMMANO Fabio;DONATI Viola;MARAZZITI Daniela;DI PIETRO Chiara;DI SPIEZIO Alessandro;
2026

Abstract

The present invention relates to the use of a direct antibody, with a high degree of affinity and specificity, against the extracellular domain of the hemichannels formed by connexin 26 (Cx26, encoded by GJB2), connexin 30 (Cx30, encoded by GJB6) and/or connexin 32 (Cx32, encoded by GJB1), to treat brain tumours and epilepsy correlated thereto or to reduce or inhibit the development thereof.
2026
Istituto di Biochimica e Biologia Cellulare - IBBC - Sede Secondaria Monterotondo
Istituto di Neuroscienze - IN - Sede Secondaria Padova
Epilepsy
Antibody
Connexin
Brain tumor
File in questo prodotto:
File Dimensione Formato  
Front page W02026047782.png

accesso aperto

Descrizione: Front page Brevetto
Tipologia: Abstract
Licenza: Dominio pubblico
Dimensione 132.38 kB
Formato image/png
132.38 kB image/png Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/573073
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact